Know Cancer

or
forgot password
  • cancer clinical trials in charlotte, NC

  • S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Breast Cancer, Metastatic Cancer
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

    Charlotte, North Carolina
    Mycoses, Candidiasis, Invasive, Candidemia
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Anal Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Prostate Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Bladder Cancer
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Recurrent Endometrial Carcinoma
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
    Presbyterian Health Care
    Charlotte, North Carolina 28204
    Breast Cancer
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Breast Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Neuroblastoma
    Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Lymphoma
    Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Prostate Cancer
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Lung Cancer, Radiation Toxicity
    Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Recurrent Mantle Cell Lymphoma
    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Extraocular Retinoblastoma
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
    Levine Children's Hospital
    Charlotte, North Carolina 28204
    Neuroblastoma, Medulloblastoma
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Carolinas Medical Center - Blumenthal Cancer Center

    Trial Locations
    Carolinas Medical Center - Blumenthal Cancer Center
    Carolinas Hematology Oncology Associates - Harris Blvd.
    Carolinas Hematology-Oncology - John J. Delaney
    Mecklenburg Medical Group - Cameron Valley Pkwy
    Mecklenburg Medical Group - Morehead Medical Dr
    Breast Cancer
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    Blumenthal Cancer Center, Carolinas Medical Center
    Charlotte, North Carolina 28204
    High Risk Stage III Melanoma
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Venous Thrombosis
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Leukemia
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Esophageal Cancer
    Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Head and Neck Cancer, Xerostomia
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Lung Cancer
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Carolinas Healthcare
    Charlotte, North Carolina
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Colorectal Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes